Search results for: infliximab

New Guidance for Rheumatologists who Treat JIA

Kathy Hollimon, Med | April 13, 2011

Evidence and consensus-based recommendations reflects current knowledge about initiation of therapy

Information on New Approvals and Medication Safety

Staff | February 12, 2011

February’s Coding Challenge

Frank Buttgereit, MD | January 17, 2011

Time is of the essence in balancing risks and benefits

Bruce N. Cronstein, MD | January 17, 2011

The missed message on methotrexate

Elizabeth A. Kitsis, MD, MBE, Michele Meltzer, MD, MBE, and C. Ronald MacKenzie, MD | January 17, 2011

Understanding the challenges in rheumatology today

Vanessa Caceres | December 1, 2010

What is safe and what to avoid in this patient population

Kathy Holliman | October 1, 2010

TNF blockers decrease symptoms but seem to have little impact on structural damage

Anja Strangfeld, MD, and Angela Zink, PhD | October 1, 2010

Tumor necrosis factor alpha inhibition and the risk of solid malignancies

Martin Aringer, MD, and Maria Dall’Era, MD | September 1, 2010

Reckless approach versus missed opportunity?